Fluorocholine (18F) CIS Bio International 225 Mbq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluorocholine (18f) cis bio international 225 mbq/ml inj. sol. i.v. vial

cis bio international - fluorocholine (18 f) 225 mbq/ml - solution for injection - 225 mbq/ml - fluorocholine (f-18) 225 mbq/ml - fluoromethylcholine (18f)

Fluorodopa 18F Cis Bio International 90 MBq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluorodopa 18f cis bio international 90 mbq/ml inj. sol. i.v. vial

cis bio international - fluorodopa (18 f) 90 mbq/ml - solution for injection - 90 mbq/ml - fluorodopa (f-18) - fluorodopa (18f)

Sodium Fluoride (18F) Life Radiopharma 0.1 GBq/ml - 4 GBq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sodium fluoride (18f) life radiopharma 0.1 gbq/ml - 4 gbq/ml inj. sol. i.v. vial

life radiopharma berlin gmbh - sodium fluoride (18 f) 100 mbq/ml - 4000 mbq/ml - solution for injection - 0,1-4 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)

Pylclari European Union - English - EMA (European Medicines Agency)

pylclari

curium pet france - piflufolastat (18f) - prostatic neoplasms - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent.pylclari is indicated for use with positron emission tomography (pet).